October 7(Wed)-9(Fri),2026
BioJapan at PACIFICO Yokohama
Experience a special event by NINEJP,
Japan’s largest platform for university-launched,
R&D-focused startups.
CONTENTS
-
October 8 (Thu) 13:00-18:30
Global Pitch
Conference
Pitches by researchers and university-based startups recommended by nine platforms across Japan, followed by a Networking session where participants can connect directly with the presenters.
Learn more about Global Pitch Conference
-
October 9 (Fri) 14:30-16:30
Special Panel
& Pitch Session
(Photo courtesy of Imperial Enterprise Lab / WE Innovate)
A session exploring creative challenges and global opportunities through a panel discussion and a pitch competition featuring women entrepreneurs.Learn more about Special Panel & Pitch Session
-
October 7 (Wed) – 9 (Fri)
Booth Exhibition
Cutting-edge research seeds and university-based startups from across Japan, with direct outreach and business meetings available through BioJapan's paid partnering system.
Learn more about Booth Exhibition
What is BioJapan 2026?
First held in 1986, BioJapan is the world's longest-running international biotechnology exhibition.
In 2025, it welcomed 22,167 visitors and 1,134 exhibiting companies and organizations. Through exhibitions, seminars, and its paid partnering system, BioJapan provides a business-matching platform that promotes industry–academia–government collaboration and open innovation in Japan and abroad. Free visitor registration for BioJapan provides access to NINEJP sessions and booth exhibits.
Global Pitch
Conference
NINEJP Innovation Award in BioJapan2026
Research Seeds Session
Academia Research Seeds Session
Presentation pitches by researchers from nine platforms across Japan.
(Presentations in English / Simultaneous Interpretation Available)
The following pages, which provide an overview of each researcher's or team's research, will also be published on a rolling basis:
・researchmap
・Made in Campus
Partnering account holders may also contact the researchers or teams in advance. The partnering service is a paid BioJapan service.
Startup Session
Startup Session
Presentation pitches by startups from nine platforms across Japan.
(Presentations in English / Simultaneous Interpretation Available)
The following pages, which provide an overview of each company's research, will also be published on a rolling basis:
・researchmap
・Made in Campus
Partnering account holders may also contact the companies in advance. The partnering service is a paid BioJapan service.
Pitch Judge
Information on the Pitch Judges
Judged by accelerators and venture capitalists
with expertise in life sciences and biotechnology
-

Imperial College London
Chantelle Young
-

Imperial College London
Nadia Ahrazem
-

UC San Diego
Dennis Abremski
-

Alumni Ventures
Michael Phillips
-

AN Venture Partners
Ken Horne
-

JIC Venture Growth Investments Co., Ltd.
Hanae Suzuki
-

Ciconia Bioventures Inc.
Takahiko Yano
-

Keio Innovation Initiative, Inc.
Tomokatsu Hongo
-

Nippon Boehringer Ingelheim Co., Ltd.
Tomoko Maeda
-

Fast Track Initiative, Inc.
Hiroko Kimura
-

Hitotsubashi Innovation Capital Co., Ltd.
Tomoko Numata
-

KPMG AZSA LLC
Daiki Sato
FoundersNation, Co. Ltd
Masaru Nagura
NetWorking
Award & Networking Sponsored by LINK-J
*Please note that Networking requires separate registration in addition to registration for the Global Pitch Conference and will be held at a different venue.
Special Panel & Pitch Session
Courage to Create:
Inspiring Journeys
of Women
Entrepreneurs
This session combines a panel discussion and pitch session to highlight the innovation and global potential of women entrepreneurs. The first half of the session features a panel discussion exploring key challenges and strategies for supporting women entrepreneurs in expanding globally. The session will then shift to a pitch showcase featuring teams from Imperial College London's WE Innovate program, alongside women entrepreneurs and researchers from Japan's NINEJP platforms. Featuring experts and entrepreneurs from the United Kingdom and Japan, the session offers valuable insights and networking opportunities for aspiring innovators and ecosystem stakeholders alike.
Booth Exhibition Next Bio-Innovation for the Future: From Lab to Global Markets
In collaboration with medU-net, a medical industry-academia collaboration network, we will showcase promising research seeds from academia and innovative startups through exhibitions and short presentations.
-
HSFC
Kitami Institute of Technology
Development culture media and process using AI and analytical technologies.
-
HSFC
LMusubi Co., Ltd
A Hokkaido University technology cutting microbial testing from 48 hours to half a day
-
MASP
SiccaNova Therapeutics Co., Ltd.
Xerostomia Therapy Designed to Balance Efficacy and Tolerability by Enhancing Physiological Salivary Secretion
-
MASP
Blue Practice Co.,Ltd.
Visualizing treatment expertise with biomimetic models to accelerate personalized medicine
-
IJIE
Saitama University, Graduate School of Science and Engineering
Commercialization of an Ultra-Sensitive POCT Platform Powered by AIE Nanoparticles
-
IJIE
Gunma University Initiative for Advanced Research, Division of Gene Therapy
Development of anti-cancer drugs using immune-modulating factors
-
GTIE
Yokohama City University, Department of Urology
AI Molecular Diagnostic Platform for Kidney Cancer
-
GTIE
Keihika Inc.
Excipient that opens transdermal delivery options for mid- and large-molecule drugs
-
Tongali
Fujita Health University, Research Promotion Headquarters
Cancer Gene Testing and Drug Discovery Using Patented Cultivation Technology for Human Cancer Cells.
-
TeSH
JAIST
a Nano-DDS Platform for Non-invasive Treatment and Enhanced Therapeutic Efficacy of Posterior Eye Diseases
-
KSAC
Nara Institute of Science and Technology
Introducing Advanced Neural Monitoring System Powered by Ultra-Compact Brain Sensors
-
KSAC
HOIST Corp.
NMIBC: tumor-selective, well-tolerated therapy. Pancreatic cancer: first-in-class ALKBH3 inhibitor.
-
PSI
Kagawa University, Faculty of Medicine, Department of Pharmacology
Development of the World's First ATP6AP2-Targeted Wnt Inhibitor
-
PARKS
Nagasaki University,
Graduate School of Biomedical Sciences
Development of antimicrobial-independent therapeutics for refractory mycobacterial infections, including pulmonary non-tuberculous mycobacteria Disease
-
PARKS
Oita University, Faculty of Medicine
Development of a Novel "Disease-Modifying" Polypeptide Therapeutic for Intractable Pulmonary Fibrosis
Short Presentation
Short presentations by booth exhibitors will be held.
Please click the button on the right to view the detailed schedule.
INFORMATION
- Date
- October 7 (Wed) – 9 (Fri), 2026
- Venue
-
〒220-0012 1-1-1 Minatomirai, Nishi-ku, Yokohama
- Venue configuration
-
- North 3F
-
- North 4F
-
G404: Networking
- Annex Hall
-
F205: Special Panel &
Pitch Session - Exhibition Hall
-
B-04 Booth Exhibition





























































